DuPont and Chemours Settle PFOA Suits
DuPont and plaintiffs’ attorneys in the Ohio multi-district litigation (MDL) have jointly agreed to a settlement in principle of the MDL involving about 3,550 lawsuits related to PFOA personal injury claims arising from environmental releases of PFOA (perfluorooctanoic acid and its salts) from the Washington Works plant in West Virginia. The total settlement amount is $670.7 million in cash, half of which will be paid by Chemours and half paid by DuPont, however both companies have denied any wrongdoing.
This settlement encompasses all claims pending in the MDL, including those matters for which jury verdicts have been rendered. DuPont discontinued PFOA operations at that plant more than a decade ago. The settlement agreement is subject to receipt of releases or dismissals, as applicable, from individual plaintiffs, among other conditions.
To address potential PFOA liabilities that might arise in the future, Chemours and DuPont have agreed that for a period of five years Chemours would annually pay PFOA liabilities outside the settlement up to $25 million, and that if such amount is exceeded, DuPont would pay any excess liabilities up to the next $25 million, with Chemours annually paying any further excess liabilities. After the five-year period, Chemours indemnification obligations under the Separation Agreement continue unchanged and DuPont has no commitment to fund PFOA costs.
Chemours has also agreed that upon the settlement becoming effective, it will not contest its liability to DuPont under the separation agreement for PFOA costs, based on ostensible defences Chemours believes are generally applicable to the indemnification provisions under the Separation Agreement. These include that such costs relate to punitive damages, fines or penalties or attorneys' fees for the same, but has retained defences as to whether any particular PFOA claim is within the scope of the indemnification provisions of the Separation Agreement.
This article has been republished from materials provided by DuPont. Note: material may have been edited for length and content. For further information, please contact the cited source.
The Ancient Behaviour of Sleep, Conserved Throughout EvolutionNews
The finding that jellyfish sleep implies that sleep is an ancient behavior, largely untouched by millennia of evolution.READ MORE
Gene Immunotherapy Approach Prevents and Reverses Symptoms of Multiple SclerosisNews
Researchers used a viral vector to deliver a gene encoding a myelin sheath protein to the liver, thereby inducing robust and durable immune tolerance in mice by preventing T cells from attacking the myelin sheath.READ MORE
Genetic Code of Neuronal Communication Determines Cell TypeNews
The findings should help scientists sort out the bewildering array of neurons that are intertwined in the brain.READ MORE